IFF
International Flavors & Fragrances Inc. NYSE Listed Dec 17, 1974$78.26
After hrs
$81.05
+0.00%
Mkt Cap $20.0B
52w Low $59.14
75.5% of range
52w High $84.45
50d MA $72.54
200d MA $68.82
P/E (TTM)
-48.5x
EV/EBITDA
29.9x
P/B
1.3x
Debt/Equity
0.5x
ROE
2.0%
P/FCF
67.4x
RSI (14)
—
ATR (14)
—
Beta
1.03
50d MA
$72.54
200d MA
$68.82
Avg Volume
1.7M
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
521 West 57th Street · New York City, NY 10019-2960 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 1.08 | 0.66 | -38.9% | 70.77 | +14.2% | +17.2% | +10.6% | — | — | — | — |
| Feb 11, 2026 | AMC | 0.83 | 0.80 | -3.4% | 76.97 | +2.5% | +5.9% | +7.8% | +7.5% | +7.8% | +6.0% | — |
| Nov 4, 2025 | AMC | 1.02 | 1.05 | +2.9% | 61.49 | +2.0% | +4.1% | +2.2% | +0.8% | +2.1% | +6.2% | — |
| Aug 5, 2025 | AMC | 1.12 | 1.15 | +2.7% | 70.62 | +4.7% | -6.3% | -9.0% | -10.0% | -10.1% | -8.6% | — |
| May 6, 2025 | AMC | 1.13 | 1.20 | +6.2% | 79.20 | -2.0% | -7.1% | -6.5% | -7.3% | -3.6% | -3.4% | — |
| Feb 18, 2025 | AMC | 0.83 | 0.97 | +16.9% | 86.45 | -6.3% | -5.2% | -7.3% | -7.6% | -7.9% | -7.1% | — |
| Nov 5, 2024 | AMC | 1.07 | 1.04 | -2.8% | 99.10 | -4.1% | -11.6% | -8.2% | -6.9% | -8.0% | -9.8% | — |
| Aug 6, 2024 | AMC | 0.99 | 1.16 | +16.7% | 96.48 | +2.8% | -2.4% | -1.0% | -0.3% | -0.7% | +0.1% | — |
| May 6, 2024 | AMC | 0.86 | 1.13 | +31.7% | 88.66 | +4.4% | +6.4% | +9.7% | +9.5% | +9.6% | +8.9% | — |
| Feb 20, 2024 | AMC | 0.75 | 0.72 | -4.0% | 82.03 | -9.2% | -6.4% | -3.1% | -1.9% | -5.6% | -9.3% | — |
| Nov 6, 2023 | AMC | 0.76 | 0.89 | +17.1% | 72.34 | +7.8% | -1.0% | -1.8% | -1.1% | -0.8% | -1.5% | — |
| Aug 7, 2023 | AMC | 1.10 | 0.86 | -21.8% | 80.34 | -22.0% | -19.4% | -20.6% | -21.3% | -20.0% | -19.1% | — |
| May 8, 2023 | AMC | 0.89 | 0.87 | -2.2% | 97.14 | -3.9% | -7.0% | -10.7% | -12.1% | -14.4% | -13.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $72.42 | $72.94 | +0.7% | -1.7% | -2.0% | -1.8% | -2.0% | -2.3% |
| Apr 14 | Barclays | Maintains | Overweight → Overweight | — | $71.70 | $71.50 | -0.3% | +1.2% | -0.2% | +0.5% | +5.8% | +3.8% |
| Apr 13 | Citigroup | Maintains | Buy → Buy | — | $72.52 | $71.97 | -0.8% | -1.1% | +0.1% | -1.4% | -0.6% | +4.6% |
| Apr 9 | UBS | Maintains | Neutral → Neutral | — | $73.77 | $72.82 | -1.3% | -0.9% | -1.7% | -2.8% | -1.6% | -3.0% |
| Feb 17 | Mizuho | Maintains | Outperform → Outperform | — | $83.00 | $84.00 | +1.2% | -0.3% | -0.0% | -1.7% | -1.9% | -0.9% |
| Feb 17 | Barclays | Maintains | Overweight → Overweight | — | $83.00 | $84.00 | +1.2% | -0.3% | -0.0% | -1.7% | -1.9% | -0.9% |
| Feb 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $81.50 | $82.50 | +1.2% | +1.8% | +1.5% | +1.8% | +0.1% | -0.1% |
| Feb 13 | Citigroup | Maintains | Buy → Buy | — | $81.50 | $82.50 | +1.2% | +1.8% | +1.5% | +1.8% | +0.1% | -0.1% |
| Feb 13 | Oppenheimer | Upgrade | Perform → Outperform | — | $81.50 | $82.50 | +1.2% | +1.8% | +1.5% | +1.8% | +0.1% | -0.1% |
| Feb 12 | Mizuho | Maintains | Outperform → Outperform | — | $76.97 | $78.88 | +2.5% | +5.9% | +7.8% | +7.5% | +7.8% | +6.0% |
| Jan 22 | Argus | Maintains | Buy → Buy | — | $71.30 | $71.51 | +0.3% | +1.2% | +2.7% | +3.8% | +2.7% | +1.2% |
| Jan 21 | Citigroup | Maintains | Buy → Buy | — | $70.86 | $71.50 | +0.9% | +0.6% | +1.8% | +3.3% | +4.5% | +3.3% |
| Jan 12 | UBS | Maintains | Neutral → Neutral | — | $69.10 | $69.42 | +0.5% | -0.2% | +0.7% | +1.6% | +2.5% | +3.7% |
| Nov 7 | Barclays | Maintains | Overweight → Overweight | — | $62.85 | $63.16 | +0.5% | -1.4% | -0.1% | +3.9% | +4.1% | +7.3% |
| Nov 6 | UBS | Maintains | Neutral → Neutral | — | $64.00 | $64.32 | +0.5% | -1.8% | -3.1% | -1.9% | +2.0% | +2.2% |
| Oct 14 | BofA Securities | Maintains | Buy → Buy | — | $60.10 | $60.00 | -0.2% | +2.6% | +3.0% | +4.2% | +6.1% | +7.6% |
| Oct 7 | Argus | Maintains | Buy → Buy | — | $61.50 | $61.85 | +0.6% | -0.8% | -0.3% | -2.2% | -3.2% | -2.3% |
| Oct 6 | UBS | Maintains | Neutral → Neutral | — | $62.18 | $62.05 | -0.2% | -1.1% | -1.9% | -1.4% | -3.3% | -4.2% |
| Oct 6 | Citigroup | Maintains | Buy → Buy | — | $62.18 | $62.05 | -0.2% | -1.1% | -1.9% | -1.4% | -3.3% | -4.2% |
| Oct 3 | Mizuho | Maintains | Outperform → Outperform | — | $61.51 | $61.35 | -0.3% | +1.1% | -0.0% | -0.8% | -0.3% | -2.2% |
| Sep 22 | Morgan Stanley | Maintains | Overweight → Overweight | — | $63.53 | $63.33 | -0.3% | -2.1% | -1.8% | -1.6% | -5.1% | -4.4% |
| Sep 8 | Wolfe Research | Upgrade | Underperform → Peer Perform | — | $66.03 | $67.03 | +1.5% | +0.2% | -1.5% | -2.3% | +0.5% | -0.6% |
| Aug 26 | Tigress Financial | Maintains | Buy → Buy | — | $67.14 | $67.11 | -0.0% | -0.6% | -0.5% | -0.1% | +0.6% | -0.9% |
| Aug 8 | Barclays | Maintains | Overweight → Overweight | — | $64.23 | $64.50 | +0.4% | -1.0% | -1.2% | +0.5% | +3.5% | +2.3% |
| Aug 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $66.16 | $65.79 | -0.6% | -2.9% | -3.9% | -4.1% | -2.4% | +0.5% |
| Aug 6 | UBS | Maintains | Neutral → Neutral | — | $70.62 | $73.94 | +4.7% | -6.3% | -9.0% | -10.0% | -10.1% | -8.6% |
| May 13 | Morgan Stanley | Maintains | Overweight → Overweight | — | $76.35 | $76.50 | +0.2% | +0.2% | -2.3% | -0.3% | +1.8% | +1.3% |
| May 8 | Citigroup | Maintains | Buy → Buy | — | $73.59 | $74.70 | +1.5% | +0.7% | -0.2% | +3.8% | +4.0% | +1.4% |
| May 8 | Barclays | Upgrade | Equal Weight → Overweight | — | $73.59 | $74.70 | +1.5% | +0.7% | -0.2% | +3.8% | +4.0% | +1.4% |
| May 8 | Baird | Maintains | Outperform → Outperform | — | $73.59 | $74.70 | +1.5% | +0.7% | -0.2% | +3.8% | +4.0% | +1.4% |
| May 7 | UBS | Maintains | Neutral → Neutral | — | $79.20 | $77.59 | -2.0% | -7.1% | -6.5% | -7.3% | -3.6% | -3.4% |
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $72.71 | $73.51 | +1.1% | +2.7% | +4.3% | +5.4% | +4.9% | +4.9% |
| Apr 15 | Mizuho | Maintains | Outperform → Outperform | — | $73.48 | $73.14 | -0.5% | -1.3% | -3.3% | -1.3% | -1.0% | +1.6% |
| Apr 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $73.17 | $73.77 | +0.8% | +0.4% | -0.9% | -2.9% | -0.9% | -0.6% |
| Apr 10 | Stifel | Maintains | Buy → Buy | — | $72.97 | $72.28 | -0.9% | -2.2% | +0.3% | +0.7% | -0.7% | -2.6% |
| Apr 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $72.97 | $72.28 | -0.9% | -2.2% | +0.3% | +0.7% | -0.7% | -2.6% |
| Apr 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $66.85 | $66.31 | -0.8% | +9.2% | +6.8% | +9.5% | +9.9% | +8.4% |
| Apr 8 | Citigroup | Maintains | Buy → Buy | — | $70.71 | $71.69 | +1.4% | -5.5% | +3.2% | +0.9% | +3.5% | +3.9% |
| Mar 27 | Barclays | Maintains | Equal Weight → Equal Weight | — | $77.66 | $77.69 | +0.0% | +0.7% | -1.5% | -0.1% | -0.3% | +1.2% |
| Feb 20 | Oppenheimer | Maintains | Outperform → Outperform | — | $81.99 | $81.56 | -0.5% | -2.3% | -2.6% | -2.9% | -2.1% | -1.7% |
| Feb 20 | BofA Securities | Maintains | Buy → Buy | — | $81.99 | $81.56 | -0.5% | -2.3% | -2.6% | -2.9% | -2.1% | -1.7% |
| Feb 20 | JP Morgan | Maintains | Overweight → Overweight | — | $81.99 | $81.56 | -0.5% | -2.3% | -2.6% | -2.9% | -2.1% | -1.7% |
| Feb 20 | Wells Fargo | Maintains | Overweight → Overweight | — | $81.99 | $81.56 | -0.5% | -2.3% | -2.6% | -2.9% | -2.1% | -1.7% |
| Feb 3 | Stifel | Maintains | Buy → Buy | — | $87.09 | $85.38 | -2.0% | -0.8% | -1.7% | -1.0% | -1.6% | -3.2% |
| Jan 28 | Oppenheimer | Maintains | Outperform → Outperform | — | $87.63 | $87.36 | -0.3% | -1.2% | -1.9% | +0.1% | -0.6% | -1.4% |
| Jan 17 | Barclays | Maintains | Equal Weight → Equal Weight | — | $84.44 | $84.81 | +0.4% | +0.5% | +1.3% | +1.2% | +2.4% | +1.7% |
| Jan 7 | Argus | Upgrade | Hold → Buy | — | $82.11 | $83.11 | +1.2% | +0.5% | -0.0% | -0.9% | +1.4% | +1.9% |
| Dec 18 | Citigroup | Maintains | Buy → Buy | — | $86.77 | $86.30 | -0.5% | -1.6% | -1.0% | -1.2% | -2.3% | -1.9% |
| Nov 12 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $91.21 | $91.64 | +0.5% | -2.0% | -1.5% | -2.0% | -5.6% | -5.0% |
| Nov 7 | Vertical Research | Upgrade | Hold → Buy | — | $87.57 | $88.15 | +0.7% | +3.9% | +5.4% | +4.2% | +2.1% | +2.6% |
No insider trades available.
Data updated apr 25, 2026 3:04pm
· Source: massive.com